|
NUS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62414526272414E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
9.56249968098177E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62481139653892E-12 |
| Stage1-vs-Stage2 |
6.680200E-01 |
| Stage1-vs-Stage3 |
5.522600E-03 |
| Stage1-vs-Stage4 |
2.861000E-03 |
| Stage2-vs-Stage3 |
2.201900E-02 |
| Stage2-vs-Stage4 |
6.183700E-03 |
| Stage3-vs-Stage4 |
4.138000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
2.25159999999169E-05 |
| Normal-vs-Asian |
1.67865721323324E-12 |
| Caucasian-vs-AfricanAmerican |
2.408400E-01 |
| Caucasian-vs-Asian |
7.076000E-01 |
| AfricanAmerican-vs-Asian |
3.301800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
2.789200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62658775337832E-12 |
| Normal-vs-Age(81-100Yrs) |
8.11920000000077E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.463040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.007400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.658400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.467800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.211600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.428600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.91979999999825E-05 |
| Classical-VS-Follicular |
2.301800E-03 |
| Classical-VS-Other |
4.959600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.68830000377451E-08 |
| Tall-VS-Other |
2.684200E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.388370E-01 |
| Follicular-VS-Normal |
2.55170000018623E-07 |
| Other-VS-Normal |
6.22759999999722E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77475828372553E-15 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
9.201200E-04 |
|
|
